Development of an HEK293 Suspension Cell Culture Medium, Transient Transfection Optimization Workflow, and Analytics for Batch rAAV Manufacturing
Biotechnology and Bioengineering · 2025-07 · 122 (7) · 1640-1655
DOI: 10.1002/bit.28980 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 08.04.2025. Verfasst von Erica A Green und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware, USA. Hauptthemen laut MEDLINE: Transfection, Culture Media, Dependovirus, Genetic Vectors. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: This study was funded and supported by the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC) through the Industry - University Cooperative Research….
Abstract (Originalsprache)
Recombinant adeno associated virus (rAAV) vectors have become popular delivery vehicles for in vivo gene therapies, but demand for rAAVs continues to outpace supply. Platform processes for rAAV production are being developed by many manufacturers, and transient chemical transfection of human embryonic kidney 293 (HEK293) cells is currently the most popular approach. However, the cutting edge nature of rAAV process development encourages manufacturers to keep cell culture media formulations, plasmid sequences, and other details proprietary, which creates hurdles for small companies and academic labs seeking to innovate in this space. To address this problem, we leveraged the resources of an academic‐industry consortium (Advanced Mammalian Biomanufacturing Innovation Center, AMBIC) to develop an rAAV production system based on transient transfection of suspension HEK293 cells adapted to an in‐house, chemically defined medium. We found that balancing iron and calcium levels in the medium were crucial for maintaining transfection efficiency and minimizing cell aggregation, respectively. A design of experiments approach was used to optimize the transient transfection process for batch rAAV production, and PEI:DNA ratio and cell density at transfection were the parameters with the strongest effects on vector genome (VG) titer. When the optimized transient process was transferred between two university sites, VG titers were within a twofold range. Analytical characterization showed that purified rAAV from the AMBIC process had comparable viral protein molecular weights versus vector derived from commercial processes, but differences in transducing unit (TU) titer were observed between vector preps. The developed media formulation, transient transfection process, and analytics for VG titer, capsid identity, and TU titer constitute a set of workflows that can be adopted by others to study fundamental problems that could improve product yield and quality in the nascent field of rAAV manufacturing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biomolecular Engineering, University of Delaware, Newark, Delaware, USA.
- Department of Biomedical Engineering and Biotechnology, University of Massachusetts Lowell, Lowell, Massachusetts, USA.
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
- Department of Chemical Engineering, University of Massachusetts Lowell, Lowell, Massachusetts, USA.
- Department of Pharmaceutical Sciences, University of Massachusetts Lowell, Lowell, Massachusetts, USA.
- MassBiologics, University of Massachusetts Chan Medical School, Fall River, Massachusetts, USA.
ORCID-Profile: Nelson Ndahiro, Kelvin H Lee, Michael Betenbaugh, Seongkyu Yoon, David J McNally
Förderung
- This study was funded and supported by the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC) through the Industry - University Cooperative Research…
Zitieren
APA
Green, E. A., Fu, Q., Ndahiro, N., Leibiger, T. M., Wang, Y., Lee, Y., Lee, K. H., Betenbaugh, M., Yoon, S., & McNally, D. J. (2025). Development of an HEK293 Suspension Cell Culture Medium, Transient Transfection Optimization Workflow, and Analytics for Batch rAAV Manufacturing. Biotechnology and Bioengineering, 122(7), 1640-1655. https://doi.org/10.1002/bit.28980
Vancouver
Green EA, Fu Q, Ndahiro N, Leibiger TM, Wang Y, Lee Y, et al. Development of an HEK293 Suspension Cell Culture Medium, Transient Transfection Optimization Workflow, and Analytics for Batch rAAV Manufacturing. Biotechnology and Bioengineering. 2025;122(7):1640-1655. doi:10.1002/bit.28980
BibTeX
@article{Green2025,
author = {Green, Erica A and Fu, Qiang and Ndahiro, Nelson and Leibiger, Thomas M and Wang, Yongdan and Lee, Yongsuk and Lee, Kelvin H and Betenbaugh, Michael and Yoon, Seongkyu and McNally, David J},
title = {Development of an HEK293 Suspension Cell Culture Medium, Transient Transfection Optimization Workflow, and Analytics for Batch rAAV Manufacturing},
journal = {Biotechnology and Bioengineering},
year = {2025},
volume = {122},
number = {7},
pages = {1640--1655},
doi = {10.1002/bit.28980}
}
EUVIMED